Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy for onychomycosis.

J H Olafsson1, B Sigurgeirsson, R Baran

  • 1Department of Dermatology, Landspitali University Hospital, Tverholt 18, 105 Reykjavik, Iceland. jonho@hudlaeknastodin.is

The British Journal of Dermatology
|September 27, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Position statement: Recommendations on the diagnosis and treatment of Malassezia folliculitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Nail lichen planus: A review of clinical presentation, diagnosis and therapy.

Annales de dermatologie et de venereologie·2022
Same author

Longitudinal subungual acanthoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Abrikossof granular cell tumor at the nail unit: An exceptional location.

Annales de dermatologie et de venereologie·2021
Same author

Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

A survey among dermatologists: diagnostics of superficial fungal infections - what is used and what is needed to initiate therapy and assess efficacy?

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same journal

Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?

The British journal of dermatology·2026
Same journal

Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.

The British journal of dermatology·2026
Same journal

Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

The British journal of dermatology·2026
Same journal

Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients.

The British journal of dermatology·2026
Same journal

Improving Prognostication for Cutaneous Squamous Cell Carcinoma.

The British journal of dermatology·2026
Same journal

Recurrent and novel GLTP variants in five patients with nonsyndromic epidermal differentiation disorder: phenotypic and genotypic expansion.

The British journal of dermatology·2026
See all related articles

Onychomycosis (fungal nail infection) monotherapy often leads to relapse. Combination antifungal therapies, combining oral and topical treatments, show improved long-term cure rates compared to single-drug approaches.

Area of Science:

  • Mycology
  • Dermatology
  • Pharmacology

Background:

  • Onychomycosis (fungal nail infection) presents a significant challenge in treatment due to high relapse rates with monotherapy.
  • The LION Study's Icelandic cohort indicated low long-term disease-free rates (46% for terbinafine, 13% for itraconazole) after 5 years, highlighting the limitations of monotherapy.

Purpose of the Study:

  • To evaluate the efficacy of combination antifungal therapies for onychomycosis.
  • To compare combination therapy outcomes against monotherapy in managing fungal nail infections.

Main Methods:

  • Review of existing combination therapy trials for onychomycosis.
  • Analysis of drug combinations including oral and topical antifungal agents.
  • Consideration of sequential versus parallel administration strategies.

Related Experiment Videos

Main Results:

  • Combination therapy is generally advantageous over monotherapy for onychomycosis treatment.
  • Specific combinations like amorolfine with terbinafine or itraconazole show promise.
  • Parallel therapy is suggested for high-risk patients (e.g., diabetics), while sequential therapy suits non-responders.

Conclusions:

  • Combination antifungal therapy offers superior outcomes for onychomycosis compared to monotherapy.
  • Strategic administration (sequential or parallel) can optimize treatment success based on patient risk factors.
  • Further research with standardized trial durations is needed to definitively compare various combination regimens.